Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$1.83B |
| 2 |
CELG
Celgene Corp
CELG
|
+$1.52B |
| 3 |
UBS Group
UBS
|
+$1.11B |
| 4 |
Johnson & Johnson
JNJ
|
+$920M |
| 5 |
Bank of America
BAC
|
+$919M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$2.98B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.37B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.33B |
| 4 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$931M |
| 5 |
Coca-Cola
KO
|
+$880M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.24% |
| 2 | Financials | 15.7% |
| 3 | Technology | 13.61% |
| 4 | Consumer Discretionary | 10.27% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
JetBlue
JBLU
$2.19B
| $514M | 0.07% |
32,425,524
-6,939,035
| -18% | -$90M |
|
|
KATE
327
DELISTED
Kate Spade & Company
KATE
| $514M | 0.07% |
16,051,136
-910,810
| -5% | -$26M |
|
328
Edwards Lifesciences
EW
$54B
| $514M | 0.07% |
24,200,472
-5,575,560
| -19% | -$112M |
|
329
United Therapeutics
UTHR
$22.1B
| $513M | 0.07% |
3,960,368
-141,028
| -3% | -$18.2M |
|
330
Fossil Group
FOSL
$310M
| $512M | 0.07% |
4,624,640
+6,802
| +0.1% | +$710K |
|
331
Whirlpool
WHR
$2.84B
| $512M | 0.07% |
2,641,712
-344,720
| -12% | -$59.2M |
|
332
Extra Space Storage
EXR
$31B
| $511M | 0.07% |
8,709,264
+1,264,875
| +17% | +$72.5M |
|
333
UDR
UDR
$12B
| $509M | 0.07% |
16,520,098
+1,526,407
| +10% | +$45.8M |
|
334
Wolfspeed
WOLF
$1.57B
| $509M | 0.07% |
15,789,069
-1,471
| -0% | -$48.3K |
|
335
Southern Company
SO
$106B
| $507M | 0.07% |
10,328,958
+121,564
| +1% | +$5.74M |
|
336
Aflac
AFL
$60.7B
| $503M | 0.07% |
16,456,022
+2,077,418
| +14% | +$61.4M |
|
337
American Electric Power
AEP
$67.3B
| $502M | 0.07% |
8,262,925
+456,020
| +6% | +$26.1M |
|
338
Gen Digital
GEN
$17.4B
| $500M | 0.07% |
19,499,607
+2,918,340
| +18% | +$72.6M |
|
|
ICPT
339
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $500M | 0.07% |
3,203,951
+21,258
| +0.7% | +$3.93M |
|
340
AXIS Capital
AXS
$7.35B
| $500M | 0.07% |
9,776,952
-3,700
| -0% | -$181K |
|
|
ANSS
341
DELISTED
Ansys
ANSS
| $499M | 0.07% |
6,087,584
-551,594
| -8% | -$43.7M |
|
|
PL
342
DELISTED
PROTECTIVE LIFE CORP
PL
| $496M | 0.06% |
7,123,415
+7,673
| +0.1% | +$534K |
|
343
Madison Square Garden
MSGS
$9.47B
| $494M | 0.06% |
9,204,933
+1,153,428
| +14% | +$58.1M |
|
|
BHI
344
DELISTED
Baker Hughes
BHI
| $493M | 0.06% |
8,795,752
+6,378,128
| +264% | +$360M |
|
|
BWLD
345
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $492M | 0.06% |
2,729,912
+653,288
| +31% | +$102M |
|
346
Macy's
M
$6.45B
| $492M | 0.06% |
7,484,427
+947,840
| +15% | +$57.3M |
|
|
TWTR
347
DELISTED
Twitter, Inc.
TWTR
| $487M | 0.06% |
13,578,632
+383,401
| +3% | +$16.3M |
|
348
Sanofi
SNY
$104B
| $485M | 0.06% |
10,631,734
+5,854,249
| +123% | +$284M |
|
349
GSK
GSK
$102B
| $484M | 0.06% |
9,058,790
+1,331,432
| +17% | +$74.5M |
|
|
HDV
350
iShares Core High Dividend ETF
HDV
$15B
| $484M | 0.06% |
31,603,120
+3,602,305
| +13% | +$54.9M |
|
Similar funds
Fidelity Investments's Q4 2014 Portfolio in Review
As of Q4 2014, Fidelity Investments held 2,940 positions worth $769B, up 4.1% from $738B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Fidelity Investments's Q4 2014 filing shows 176 new, 1,100 increased, 1,140 reduced and 160 closed positions. Its largest new stake was UBS Group: 64,914,641 shares worth $1.11B. The largest sale was AbbVie, an estimated $2.98B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Financials and Technology.
- Fidelity Investments's largest Q4 2014 buy was UBS Group: 64,914,641 shares worth $1.11B.
- Fidelity Investments added most to Medtronic in Q4 2014, an estimated $1.83B increase.
- Fidelity Investments's biggest Q4 2014 reduction was AbbVie, cutting an estimated $2.98B.
- Fidelity Investments fully exited TIM HORTONS INC COM, CANADA in Q4 2014, selling an estimated $693M.
- Fidelity Investments's ten largest holdings make up 14% of its $769B portfolio in Q4 2014.
- Fidelity Investments opened 176 new positions and closed 160 in Q4 2014.
- Fidelity Investments's portfolio value rose 4.1% quarter-over-quarter to $769B.
Based on Fidelity Investments's 13F filing for Q4 2014, filed 17 Feb 2015.